可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Sperling C, Houska M, Brynda E, et al. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique[J]. J Biomed Mater Res A, 2006, 76(4): 681-689.
[2]Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation[J]. Eur J Cardiothorac Surg, 1999, 16(3): 342-350.
[3]杨剑,易定华,刘金成,等. 肝素涂层体外循环管道的制备及生物学性能评价[J].中国生物医学工程学报, 2004, 23(2):169-174.
[4]Hsu LC. Biocompatibility in cardiopulmonary bypass[J]. J Cardiothoracic Vasc Anesth, 1997, 11(3):376-382.
[5]张安兄,吕德龙,程为庄,等. 生物材料的血液相容性[J].上海生物医学工程, 2004, 25(3):53-58.
[6]杨剑,易定华. 体外循环中的肝素涂层技术[J]. 国外医学·生物医学工程分册, 2003, 26(2):89-93.
[7]Huang LY, Yang MC. Hemocompatibility of layer-by-layer hyaluronic acid/heparin nanostructure coating on stainless steel for cardiovascular stents and its use for drug delivery[J]. J Nanosci Nanotechnol, 2006, 6(9-10):3163-3170.
[8]Thorslund S, Sanchez J, Larsson R, et al. Functionality and stability of heparin immobilized onto poly(dimethylsiloxane)[J]. Colloids Surf B Biointerfaces, 2005, 45(2):76-81.
[9]Lappegard KT, Riesenfeld J, Brekke OL, et al. Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production[J]. Ann Thorac Surg, 2005, 79(3):917-923.
[10]杨剑,易定华,钟丽辉,等. 肝素涂层体外循环管道抗凝血性能的研究[J]. 生物医学工程与临床, 2003, 7(2):100-103.
[11]杨剑,易定华,刘金成,等. MTT法评价肝素涂层医用聚氯乙烯的细胞毒性 [J]. 生物医学工程与临床, 2004, 8(1):11-13.
[12]杨剑,易定华,刘金成,等. 肝素涂层医用聚氯乙烯的细胞毒性研究 [J]. 生物医学工程学杂志, 2005, 22(4):739-741.